Eisai
4523.T
#2112
Rank
HK$68.34 B
Marketcap
HK$242.46
Share price
0.79%
Change (1 day)
9.18%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.79. an increase over its 2024 EPS that were of HK$7.65.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$8.5611.85%
2024HK$7.65-32.63%
2023HK$11.365.52%
2022HK$10.76-74.01%
2021HK$41.40-66.58%
2020HK$123.8698.24%
2019HK$62.4817.01%
2018HK$53.4037.78%
2017HK$38.76-27.62%
2016HK$53.5535.33%
2015HK$39.57-2.82%
2014HK$40.72-27.66%
2013HK$56.29-27.49%
2012HK$77.63-12.67%
2011HK$88.9088.08%
2010HK$47.27-11.06%
2009HK$53.14-390.15%
2008-HK$18.32-127.78%
2007HK$65.9411.78%
2006HK$58.994.38%
2005HK$56.527.4%
2004HK$52.6343.03%
2003HK$36.8025.09%
2002HK$29.4252.67%
2001HK$19.2769.76%
2000HK$11.35